TY - JOUR
T1 - Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder
AU - Neale, Benjamin M.
AU - Medland, Sarah E.
AU - Ripke, Stephan
AU - Asherson, Philip
AU - Franke, Barbara
AU - Lesch, Klaus-Peter
AU - Faraone, Stephen V.
AU - Nguyen, Thuy Trang
AU - Schaefer, Helmut
AU - Holmans, Peter
AU - Daly, Mark
AU - Steinhausen, Hans-Christoph
AU - Freitag, Christine
AU - Reif, Andreas
AU - Renner, Tobias J.
AU - Romanos, Marcel
AU - Romanos, Jasmin
AU - Walitza, Susanne
AU - Warnke, Andreas
AU - Meyer, Jobst
AU - Palmason, Haukur
AU - Buitelaar, Jan
AU - Vasquez, Alejandro Arias
AU - Lambregts-Rommelse, Nanda
AU - Gill, Michael
AU - Anney, Richard J. L.
AU - Langely, Kate
AU - O'Donovan, Michael
AU - Williams, Nigel
AU - Owen, Michael
AU - Thapar, Anita
AU - Kent, Lindsey
AU - Sergeant, Joseph
AU - Roeyers, Herbert
AU - Mick, Eric
AU - Biederman, Joseph
AU - Doyle, Alysa
AU - Smalley, Susan
AU - Loo, Sandra
AU - Hakonarson, Hakon
AU - Elia, Josephine
AU - Todorov, Alexandre
AU - Miranda, Ana
AU - Mulas, Fernando
AU - Ebstein, Richard P.
AU - Rothenberger, Aribert
AU - Banaschewski, Tobias
AU - Oades, Robert D.
AU - Sonuga-Barke, Edmund
AU - McGough, James
AU - Psychiat GWAS Consortium ADHD Subg
N1 - Funding: This project was supported by the following grants: US National of Institute of Health Grants R13MH059126, R01MH62873, U01MH085518 and R01MH081803 to S.V. Faraone, U01MH085515 to M. Daly K23MH066275-01 to J. Elia; and R01MH58277 to S. Smalley; Institutional Development Award to the Center for Applied Genomics from the Children's Hospital of Philadelphia to H. Hakonarson. Affymetrix Power Award, 2007 to B. Franke; NHMRC (Australia) and Sidney Sax Public Health Fellowship (443036) to S.E. Medland; Wellcome Trust, UK for sample collection to L Kent. UMC Utrecht Genvlag Grant and Internal Grant of Radboud University, Nijmegen Medical Centre to J. Buitelaar, the Deutsche Forschungsgemeinschaft (KFO 125, SFB 581, GRK 1156 to K.P. Lesch, ME 1923/5-1, ME 1923/5-3, GRK 1389 to C. Freitag and J. Meyer, SCHA 542/10-3 to H. Schäfer) and the Bundesministerium für Bildung und Forschung (BMBF 01GV0605 to K.P. Lesch).
PY - 2010/9
Y1 - 2010/9
N2 - Objective Although twin and family studies have shown attention-deficit/hyperactivity disorder (ADHD) to be highly heritable, genetic variants influencing the trait at a genome-wide significant level have yet to be identified. As prior genome-wide association studies (GWAS) have not yielded significant results, we conducted a meta-analysis of existing studies to boost statistical power. Method We used data from four projects: a) the Children's Hospital of Philadelphia (CHOP); b) phase I of the International Multicenter ADHD Genetics project (IMAGE); c) phase II of IMAGE (IMAGE II); and d) the Pfizer-funded study from the University of California, Los Angeles, Washington University, and Massachusetts General Hospital (PUWMa). The final sample size consisted of 2,064 trios, 896 cases, and 2,455 controls. For each study, we imputed HapMap single nucleotide polymorphisms, computed association test statistics and transformed them to z-scores, and then combined weighted z-scores in a meta-analysis. Results No genome-wide significant associations were found, although an analysis of candidate genes suggests that they may be involved in the disorder. Conclusions Given that ADHD is a highly heritable disorder, our negative results suggest that the effects of common ADHD risk variants must, individually, be very small or that other types of variants, e.g., rare ones, account for much of the disorder's heritability.
AB - Objective Although twin and family studies have shown attention-deficit/hyperactivity disorder (ADHD) to be highly heritable, genetic variants influencing the trait at a genome-wide significant level have yet to be identified. As prior genome-wide association studies (GWAS) have not yielded significant results, we conducted a meta-analysis of existing studies to boost statistical power. Method We used data from four projects: a) the Children's Hospital of Philadelphia (CHOP); b) phase I of the International Multicenter ADHD Genetics project (IMAGE); c) phase II of IMAGE (IMAGE II); and d) the Pfizer-funded study from the University of California, Los Angeles, Washington University, and Massachusetts General Hospital (PUWMa). The final sample size consisted of 2,064 trios, 896 cases, and 2,455 controls. For each study, we imputed HapMap single nucleotide polymorphisms, computed association test statistics and transformed them to z-scores, and then combined weighted z-scores in a meta-analysis. Results No genome-wide significant associations were found, although an analysis of candidate genes suggests that they may be involved in the disorder. Conclusions Given that ADHD is a highly heritable disorder, our negative results suggest that the effects of common ADHD risk variants must, individually, be very small or that other types of variants, e.g., rare ones, account for much of the disorder's heritability.
KW - ADHD
KW - Meta-analysis
KW - Association
KW - GWAS
KW - Genetics
U2 - 10.1016/j.jaac.2010.06.008
DO - 10.1016/j.jaac.2010.06.008
M3 - Article
VL - 49
SP - 884
EP - 897
JO - Journal of the American Academy of Child and Adolescent Psychiatry
JF - Journal of the American Academy of Child and Adolescent Psychiatry
IS - 9
ER -